Bioasis Technologies (BTI.V) announced positive results today from an efficacy study of a blood-brain barrier penetrant interleukin-1 receptor inhibitor in a preclinical rodent model of multiple sclerosis (MS). “These…
multiple sclerosis
Helius Medical Technologies (HSM.T) subsidiary, Helius Medical, received the go-ahead from the Food and Drug Administration to take their portable neuromodulation stimulator (PoNS) device to market. The PoNS…
Cognetivity Neurosciences’ (CGN.C) latest scientific publication touts their Integrated Cognitive Assessment (ICA) tool as a weapon for detecting and monitoring cognitive impairment associated with neurodegenerative diseases. The ICA’s original…